Betser-Zilevitch v. Petrochina Canada Ltd., 2022 FCA 162
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Court of Appeal (Canada) |
| Citation | 2022 FCA 162 |
| Date | 28 September 2022 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
2 practice notes
-
Canadian Patent Law 2022: A Year In Review
...simultaneously arrived at the same invention establish that the invention was obvious? In Betser-Zilevitch v Petrochina Canada Ltd, 2022 FCA 162, the Federal Court of Appeal confirmed that simultaneous invention does not necessarily indicate obviousness. Holding otherwise would disregard th......
-
2022 Year In Review: Life Sciences
...3. 4 Biogen MA Inc. 2022 CACP 2. 5 Pharmascience v. Bristol-Myers Squibb Canada, 2022 FCA 142. 6 Betser-Zilevitch v. PetroChina Canada, 2022 FCA 162. 7 Biogen Canada v. Pharmascience, 2022 FCA 143. 8 Kobold Corporation v NCS Multistage Inc., 2021 FC 1437. 9 Merck v. Canada (Minister of Heal......
2 firm's commentaries
-
Canadian Patent Law 2022: A Year In Review
...simultaneously arrived at the same invention establish that the invention was obvious? In Betser-Zilevitch v Petrochina Canada Ltd, 2022 FCA 162, the Federal Court of Appeal confirmed that simultaneous invention does not necessarily indicate obviousness. Holding otherwise would disregard th......
-
2022 Year In Review: Life Sciences
...3. 4 Biogen MA Inc. 2022 CACP 2. 5 Pharmascience v. Bristol-Myers Squibb Canada, 2022 FCA 142. 6 Betser-Zilevitch v. PetroChina Canada, 2022 FCA 162. 7 Biogen Canada v. Pharmascience, 2022 FCA 143. 8 Kobold Corporation v NCS Multistage Inc., 2021 FC 1437. 9 Merck v. Canada (Minister of Heal......